Quarterly Report • Nov 10, 2020
Quarterly Report
Open in ViewerOpens in native device viewer
| in € million | Q3 / 2020 | Q3 / 2019 | Change | 9M / 2020 | 9M / 2019 | Change |
|---|---|---|---|---|---|---|
| Business Development | ||||||
| Order entry | 44.1 | 66.0 | -33.2% | 206.7 | 157.8 | 31.0% |
| Order backlog as of September 30 | 125.8 | 115.3 | 9.1% | |||
| Total sales | 60.6 | 37.1 | 63.3% | 173.9 | 131.1 | 32.6% |
| Gross profit | 24.5 | 10.9 | 124.8% | 57.7 | 39.1 | 47.6% |
| Gross margin | 40.4% | 29.4% | 11.0%-Points | 33.2% | 29.8% | 3.4%-Points |
| Cost of sales | 36.1 | 26.2 | 37.8% | 116.2 | 92.0 | 26.3% |
| Research and Development costs | 4.3 | 5.1 | -15.7% | 14.2 | 14.6 | -2.7% |
| EBITDA | 10.8 | -3.3 | -- | 17.6 | -1.3 | -- |
| EBITDA margin | 17.8% | -8.9% | 26.7%-Points | 10.1% | -1.0% | 11.1%-Points |
| EBIT | 9.0 | -4.9 | -- | 12.2 | -5.7 | -- |
| EBIT margin | 14.9% | -13.2% | 28.1%-Points | 7.0% | -4.3% | 11.4%-Points |
| Earnings after tax | 4.5 | -6.8 | -- | 4.9 | -8.7 | -- |
| Earnings per share, basic (in €) | 0.24 | -0.36 | -- | 0.26 | -0.46 | -- |
| Balance sheet and cash flow | ||||||
| Equity | 129.7 | 133.5 | -2.8% | |||
| Equity ratio | 58.4% | 66.8% | -8.4%-Points | |||
| Return on equity | 3.5% | -5.1% | 8.6%-Points | 3.8% | -6.5% | 10.3%-Points |
| Balance sheet total | 222.2 | 199.9 | 11.2% | |||
| Net cash | 15.0 | -6.6 | -- | |||
| Free cash flow | 10.6 | -9.8 | -- | 27.8 | -28.7 | -- |
| Further key figures | ||||||
| Investments | 2.5 | 1.2 | 108.3% | 8.6 | 5.0 | 72.0% |
| Investment ratio | 4.1% | 3.2% | 0.9%-Points | 4.9% | 3.8% | 1.1%-Points |
| Depreciation | 1.9 | 1.6 | 18.8% | 5.5 | 4.4 | 25.0% |
| Employees as of September 30 | 997 | 935 | 6.6% |
| Business Development in the First Three Quarters | 4 |
|---|---|
| Financial Report | 10 |
| Consolidated Statement of Income (IFRS) | 10 |
| Statement of Comprehensive Income (IFRS) | 11 |
| Consolidated Statement of Financial Position (IFRS) | 12 |
| Consolidated Statement of Cash Flows (IFRS) | 13 |
| Statement of Changes in Equity (IFRS) | 14 |
| Segment Reporting (IFRS) | 15 |
| Legal Structure | 16 |
| Financial Calendar / Contact / Imprint | 17 |
Dear Shareholders,
We look back today on an encouraging third quarter 2020. Despite the restrictions to societal and economic life with corresponding negative effects on the economy caused by the COVID-19 pandemic, we were able to complete the third quarter successfully, in particular regarding sales and EBIT.
A reason for the positive development is the increasing digitalization of our communication, which is rapidly increasing the need for high-power data networks. The need for comprehensive high-bandwidth network coverage and thereby high transmission speed is becoming visible everywhere and is driving the worldwide conversion to the new 5G cellular communication standard. The expanded production of 5G-capable cellular communication components is one of the main drivers for the increased demand for our production machines, particularly for coaters and mask aligners.
The order backlog at the end of the third quarter amounts to EUR 125.8 million after EUR 115.3 million in the previous year. We were able to increase sales in the third quarter compared to the previous year by more than 63 percent, reaching EUR 60.6 million. We were also able to significantly increase earnings before interest and taxes (EBIT) compared to the previous year from EUR -4.9 million to EUR 9.0 million. For the third quarter of 2020, this resulted in an EBIT margin of 14.9 percent compared to -13.2 percent in the previous year's quarter. The high sales, a favorable product mix as well as the good capacity utilization in production allowed for the significant increase in EBIT.
Taking the first nine months of 2020 in account, a very positive picture also emerges here. Order intake amounted to EUR 206.7 million, which corresponds to a growth of 31.0 percent compared to the previous year. Sales increased accordingly and reached an amount of EUR 173.9 million after the first nine months, which corresponds to an increase of 32.6 percent compared to the previous year. Accordingly, EBIT also developed positively and amounted to EUR 12.2 million as of September 30, 2020, after EUR -5.7 million in the comparable period of the previous year. The EBIT margin increased from -4.3 percent to 7.0 percent.
The good orders position at the start of 2020 as well as the continued high demand resulted in a significant increase in sales from the previous year's period. A constant high workload of production, low levels of absenteeism due to illness as well as the efficiency improvement measures introduced in production allowed for the significant increase in EBIT from the previous year. In addition, there are signs that the remaining and already written off production plants from the liquidation of SMT Photonic Systems Inc., California, USA, can still be sold. The third quarter already includes a scanner in sales that had a corresponding positive effect on the EBIT margin. Two additional scanners are scheduled for delivery in the fourth quarter. This partially neutralizes the negative impact on EBIT from the closure costs for the US site for 2020.
Free cash flow after three quarters amounted to EUR 27.8 million after EUR -28.7 million in the previous year. Net cash at the end of the third quarter was EUR 15.0 million after EUR - 6.6 million in the previous year. Along with the significantly improved earnings situation, the measures introduced for reducing working capital have had a very positive impact on free cash flow and the liquidity situation.
Given the good results after nine months as well as the positive outlook for the fourth quarter 2020, we maintain our expectations for sales in the range from € 240 million to € 260 million, but we are now assuming an improved EBIT margin in the range between 5.5 percent and 7.5 percent. Previously, the range for the EBIT margin was estimated at 3 percent to 5 percent. For the fourth quarter 2020 and the first quarter 2021 we expect a cumulated order entry in the range of € 100 to € 110 million. With this forecast, the company assumes that the just recently intensified global measures to contain the COVID-19 pandemic will not have any further negative effects.
Garching, Germany, November 2020
| Dr. Franz Richter | Oliver Albrecht |
|---|---|
| Chief Executive Officer | Chief Financial Officer |
The Lithography division includes the development, manufacture, and sale of the mask aligner as well as coater/developer product lines. These product lines are manufactured in Germany at the locations in Garching near Munich and in Sternenfels.
With the acquisition of SUSS MicroTec Netherlands B.V. (formerly PiXDRO), SUSS MicroTec added the option of applying photo resists and dielectric layers by means of this new process to its existing lithography product portfolio in its coater/developer segment.
| in € million | 9M 2020 | 9M 2019 |
|---|---|---|
| Order entry | 127.2 | 72.0 |
| Sales | 97.8 | 72.4 |
| Gross Profit | 29.7 | 16.1 |
| Gross Profit Margin | 30.4% | 22.2% |
| EBIT | 6.2 | -8.1 |
| EBIT-Margin | 6.3% | -11.2% |
| Net assets | 59.6 | 71.8 |
In the first nine months of 2020, order entry totaled EUR 127.2 million after EUR 72.0 million in the previous year. As a result, we were able to increase order entry in the division significantly from the previous year. The reason for this was in particular strong order entry in the coater/developer product line. Division sales in the first nine months of 2020 amounted to EUR 97.8 million after EUR 72.4 million in the previous year. This represented growth of 35.1%. The gross profit margin in the division increased from 22.2% to 30.4%. Accordingly, division earnings improved from EUR -8.1 million to EUR 6.2 million. The main reasons for the good development were high-margin sales with mask aligners as well as the significant increase in sales for coaters.
In January 2020, the decision was made to discontinue the UV projection and laser ablation product lines, which were both located California, USA. Therefore, the gross profit margin and EBIT of the Lithography division were burdened in the first nine months of 2020 by expenses for the closure of the production site in California. The closure costs for the site in California in the first nine months of 2020 totaled EUR 5.0 million, of which EUR 2.3 million was disclosed under selling, administrative, and development costs. However, an already written off production plant from the liquidation of SMT Photonic Systems Inc., California, USA, could be sold, which had a positive effect of approx. EUR 0.9 million on EBIT. Without these extraordinary effects, the Lithography division would have had a gross profit margin of 32.2% and an EBIT of EUR 10.3 million in the first nine months of 2020.
By the end of 2020, additional closure costs amounting to approx. EUR 2.0–2.5 million will arise. As a contrary effect to these closure costs, extraordinary income from selling two additional already written off production plants from the liquidation of SMT Photonic Systems Inc., California, USA, amounting to approx. EUR 1.7 million will arise. Hence, the overall extraordinary effect in the fourth quarter of 2020 will be reduced to approx. EUR 0.3–0.8 million.
The Bonder division comprises the development, production, and sale of the substrate (wafer) bonder product line. Manufacturing is located at our largest site in Sternenfels. Markets addressed by the bonder systems include microelectromechanical systems (MEMS), compound semiconductors, and 3D TSV integration.
| in € million | 9M 2020 | 9M 2019 |
|---|---|---|
| Order entry | 26.8 | 14.8 |
| Sales | 18.9 | 17.2 |
| Gross Profit | 5.6 | 5.9 |
| Gross Profit Margin | 29.6% | 34.3% |
| EBIT | -0.6 | -0.7 |
| EBIT-Margin | -3.2% | -4.1% |
| Net assets | 19.0 | 21.2 |
Order entry in the Bonder division amounted to EUR 26.8 million in the first nine months of 2020, thereby increasing by 81.1% compared to the previous year. This good development was primarily attributable to good order entry with temporary bonding systems. Sales also developed positively to EUR 18.9 million in the first nine months of 2020 after EUR 17.2 million in the previous year. The gross profit margin amounted to 29.6% after 34.3% in the previous year. At EUR -0.6 million, we were able to improve EBIT slightly after EUR -0.7 million in the previous year. The improvement in earnings is primarily attributable to cost savings in the segments of sales and research and development.
The Photomask Equipment division, which is located at the Sternenfels site, comprises the development, manufacture, and sale of specialized tools for the cleaning and processing of photomasks for the semiconductor industry. The semiconductor industry is among the markets addressed by the Photomask Equipment division. SUSS MicroTec is active here on the front end.
| in € million | 9M 2020 | 9M 2019 |
|---|---|---|
| Order entry | 35.5 | 52.5 |
| Sales | 40.0 | 24.6 |
| Gross Profit | 16.7 | 9.2 |
| Gross Profit Margin | 41.8% | 37.4% |
| EBIT | 11.0 | 4.4 |
| EBIT-Margin | 27.5% | 17.9% |
| Net assets | 18.5 | 19.6 |
In the first nine months of 2020, the Photomask Equipment division recorded order entry of EUR 35.5 million (previous year: EUR 52.5 million). The decline in order entry compared to the previous year is due to a normalization of demand in this division. Division sales were encouraging at EUR 40.0 million after EUR 24.6 million a year earlier. The gross profit margin rose from 37.4% to 41.8%. Division earnings increased significantly from EUR 4.4 million to EUR 11.0 million. This significant increase was supported by large-volume orders with very good margins.
Since order entry and sales in this division are usually comprised of a few large individual orders, significant fluctuations in order entry, sales, and therefore earnings are possible over the course of the year.
The Micro-optics division includes the activities of the SUSS MicroTec subsidiary SUSS MicroOptics at the Hauterive location in Switzerland. The production and sales of microlenses and highly-specialized optics for a variety of industrial applications are housed here.
| in € million | 9M 2020 | 9M 2019 |
|---|---|---|
| Order entry | 16.8 | 17.7 |
| Sales | 16.8 | 16.2 |
| Gross Profit | 4.9 | 6.6 |
| Gross Profit Margin | 29.2% | 40.7% |
| EBIT | 0.3 | 2.7 |
| EBIT-Margin | 1.8% | 16.7% |
| Net assets | 22.5 | 14.6 |
Order entry in this division decreased slightly and amounted to EUR 16.8 million (previous year: EUR 17.7 million) in the first nine months of 2020. Sales also increased slightly from the previous year to EUR 16.8 million (previous year: EUR 16.2 million). The gross profit margin amounted to 29.2% after 40.7% in the previous year. Division earnings totaled EUR 0.3 million after EUR 2.7 million in the previous year. Partially as a result of the COVI-19 pandemic, particularly in the Automotive segment, it was not possible to achieve the sales and earnings targets for the first nine months of 2020. The Company had to report reduced working hours in the first and second quarters. Quality concerns with a main supplier, who has now been replaced, had an additional negative impact on earnings. Development activities in order to obtain new orders in the Automotive segment also weighed on earnings.
The Others division mainly comprises costs for central Group functions that cannot be attributed to the main divisions of SUSS MicroTec SE. The central Group functions made a negative EBIT contribution of EUR -4.7 million (previous year: EUR -3.9 million). The increase in comparison to the previous year is mainly due to higher administration costs, especially consulting costs.
The SUSS MicroTec share fell to EUR 6.50 in the first quarter of 2020 following the publication of preliminary figures in January and with the start of the global economic downturn compared to a XETRA closing price of EUR 12.54 at the beginning of 2020. Over the same period, the TecDAX fell by approximately 15%. The performance of the Germany Prime IG/Semiconductor Index, which represents the largest listed German companies in the semiconductor industry including SUSS MicroTec SE, was significantly negative in the period from January to March 2020, displaying a loss of approximately 34% on March 31, 2020, compared to the beginning of the year. After the SUSS MicroTec share reached its low for the year at the beginning of April, it was able to rise significantly over the course of the second quarter. At the end of the first half of the year, the XETRA closing price was EUR 14.44, which represented a gain of 15% from the beginning of the year. In the same period, the TecDAX lost approximately 4% while the Prime IG/Semiconductor Index rose by 1%.
In the third quarter of 2020, the SUSS MicroTec share was able to continue its positive share price performance, but had to record a few setbacks at the start of the quarter in July and also in early August and fell to below EUR 13.00. After publication of the mid-year figures and confirming the annual guidance on August 6, 2020, the share price developed very positively and was at a XETRA closing price of EUR 15.82 at the end of the third quarter. This corresponds to growth of approximately 26 percent from the start of the year. In the same period, the TecDAX experienced a minor gain in share price of less than one percent, while the Prime IG Semiconductor increased by approximately 12 percent in the first nine months of 2020.
The average daily trading volume of SUSS MicroTec shares on the German XETRA stock exchange in the first nine months of 2020 amounted to approximately 71 thousand shares (previous year: average daily trading volume of approximately 26 thousand shares).
| in € thousand | 01.07.2020 - 30.09.2020 |
01.07.2019 - 30.09.2019 |
01.01.2020 - 30.09.2020 |
01.01.2019 - 30.09.2019 |
|---|---|---|---|---|
| Sales | 60,603 | 37,056 | 173,922 | 131,126 |
| Cost of sales | -36,136 | -26,162 | -116,244 | -92,038 |
| Gross profit | 24,467 | 10,894 | 57,678 | 39,088 |
| Selling costs | -5,768 | -5,513 | -15,746 | -15,791 |
| Research and development costs | -4,332 | -5,137 | -14,197 | -14,595 |
| Administration costs | -5,096 | -4,694 | -14,984 | -13,467 |
| Other operating income | 917 | 239 | 2,010 | 847 |
| Other operating expenses | -1,225 | -690 | -2,610 | -1,757 |
| Analysis of net income from operations (EBIT): | ||||
| EBITDA (Earnings before Interest and Taxes, Depreciation and Amortization) |
10,861 | -3,298 | 17,631 | -1,257 |
| Depreciation and amortization of tangible assets, intangible assets and investments in subsidiaries |
-1,898 | -1,603 | -5,480 | -4,418 |
| Net income from operations (EBIT) | 8,963 | -4,901 | 12,151 | -5,675 |
| Financial income | 0 | 0 | 3 | 9 |
| Financial expense | -33 | -66 | -355 | -176 |
| Financial result | -33 | -66 | -352 | -167 |
| Profit / loss from continuing operations before taxes | 8,930 | -4,967 | 11,799 | -5,842 |
| Income taxes | -4,380 | -1,865 | -6,891 | -2,868 |
| Profit / loss from continuing operations | 4,550 | -6,832 | 4,908 | -8,710 |
| Thereof equity holders of SUSS MicroTec | 4,550 | -6,832 | 4,908 | -8,710 |
| Thereof non-controlling interests | 0 | 0 | 0 | 0 |
| Earnings per share (basic) | ||||
| Earnings per share in € | 0.24 | -0.36 | 0.26 | -0.46 |
| Earnings per share (diluted) | ||||
| Earnings per share in € | 0.24 | -0.36 | 0.26 | -0.46 |
| in € thousand | 01.01.2020 - 30.09.2020 |
01.01.2019 - 30.09.2019 |
|---|---|---|
| Net profit / loss | 4,908 | -8,710 |
| Items that are not reclassified to profit and loss | ||
| Remeasurements on defined benefit pension plans | 0 | 0 |
| Deferred taxes | 0 | 0 |
| Other income after tax for items that are not reclassified as an expense or income |
0 | 0 |
| Items that will be reclassified to profit and loss in later periods |
||
| Foreign currency adjustment | -561 | 1,816 |
| Cash flow hedges | 0 | 0 |
| Deferred taxes | 0 | 0 |
| Other income after tax for items that will be reclassified to profit and loss in later periods |
-561 | 1,816 |
| Total income and expenses recognized in equity | -561 | 1,816 |
| Total income and expenses reported in the reporting period |
4,347 | -6,894 |
| Thereof equity holders of SUSS MicroTec SE | 4,347 | -6,894 |
| Thereof non-controlling interests | 0 | 0 |
| CONSOLIDATED STATEMENT OF FINANCIAL POSITION (IFRS) | |
|---|---|
| ----------------------------------------------------- | -- |
| in € thousand | 30.09.2020 | 31.12.2019 |
|---|---|---|
| Assets | ||
| NON-CURRENT ASSETS | 66,577 | 55,109 |
| Intangible assets | 4,780 | 4,153 |
| Goodwill | 18,378 | 15,707 |
| Tangible assets | 38,826 | 33,905 |
| Other assets | 1,061 | 568 |
| Deferred tax assets | 3,532 | 776 |
| CURRENT ASSETS | 155,581 | 144,789 |
| Inventories | 84,555 | 75,047 |
| Trade receivables | 13,941 | 18,992 |
| Contract assets | 25,706 | 31,182 |
| Other financial assets | 186 | 366 |
| Securities | 0 | 0 |
| Current tax assets | 436 | 4,708 |
| Cash and cash equivalents | 25,637 | 10,280 |
| Other assets | 5,120 | 4,214 |
| TOTAL ASSETS | 222,158 | 199,898 |
| in € thousand | 30.09.2020 | 31.12.2019 |
|---|---|---|
| Liabilities & shareholders' equity | ||
| Equity | 129,735 | 125,388 |
| Total equity attributable to shareholders of SUSS MicroTec SE |
129,735 | 125,388 |
| Subscribed capital | 19,116 | 19,116 |
| Reserves | 111,514 | 106,606 |
| Accumulated other comprehensive income | -895 | -334 |
| NON-CURRENT LIABILITIES | 35,117 | 24,468 |
| Pension plans and similar commitments | 6,482 | 6,037 |
| Financial debt | 9,375 | 10,500 |
| Financial debt from lease obligations | 7,570 | 4,638 |
| Deferred tax liabilities | 11,690 | 3,293 |
| CURRENT LIABILITIES | 57,306 | 50,042 |
| Provisions | 4,728 | 4,198 |
| Tax liabilities | 185 | 702 |
| Financial debt | 1,295 | 10,399 |
| Financial debt from lease obligations | 2,822 | 2,751 |
| Other financial liabilities | 7,189 | 6,773 |
| Trade payables | 10,962 | 10,013 |
| Contract liabilities | 23,834 | 9,346 |
| Other liabilities | 6,291 | 5,860 |
| TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY | 222,158 | 199,898 |
| in € thousand | 01.01.2020 - 30.09.2020 |
01.01.2019 - 30.09.2019 |
|---|---|---|
| Net profit / loss (after taxes) | 4,908 | -8,710 |
| Amortization of intangible assets | 474 | 838 |
| Depreciation of tangible assets | 5,006 | 3,580 |
| Profit or loss on disposal of intangible and tangible assets | -59 | 0 |
| Change of reserves on inventories | 1,496 | 2,795 |
| Change of reserves for bad debts | -171 | -56 |
| Non-cash income from the reversal of pension accruals | 0 | 0 |
| Other non-cash effective income and expenses | -164 | 235 |
| Change in inventories | -8,424 | -13,686 |
| Change in contract assets | 5,481 | -2,904 |
| Change in trade receivables | 5,558 | 5,200 |
| Change in other assets | -1,166 | 386 |
| Change in pension provisions | 433 | 32 |
| Change in trade payables | 666 | 963 |
| Change in contract liabilities | 12,219 | -4,658 |
| Change in other liabilities and other provisions | 542 | -4,983 |
| Change of tax assets and tax liabilities | 9,563 | -2,775 |
| Cash flow from operating activities | 36,362 | -23,743 |
| in € thousand | 01.01.2020 - 30.09.2020 |
01.01.2019 - 30.09.2019 |
|---|---|---|
| Disbursements for other tangible assets | -4,653 | -4,584 |
| Disbursements for intangible assets | -587 | -386 |
| Purchases of current available-for-sale securities | -3,307 | 0 |
| Cash flow from investing activities | -8,547 | -4,970 |
| Repayment of bank loans | -750 | -750 |
| Increase of bank loans | 0 | 10,000 |
| Repayment of leasing liabilities | -2,126 | -627 |
| Change in other financial debt | -9,479 | 1 |
| Cash flow from financing activities | -12,355 | 8,624 |
| Adjustments to funds caused by exchange-rate fluctuations | -103 | 178 |
| Change in cash and cash equivalents | 15,357 | -19,911 |
| Funds at beginning of the year | 10,280 | 30,672 |
| Funds at end of the period | 25,637 | 10,761 |
| Cash flow from operating activities includes: | ||
| Interest paid during the period | 250 | 92 |
| Interest received during period | 2 | 8 |
| Tax paid during the period | 2,197 | 5,221 |
| Tax refunds during the period | 5,230 | 134 |
| in € thousand | Subscribed capital |
Additional paid-in capital |
Earnings reserve |
Retained earnings |
Accumulated other comprehensive income | to shareholders of SÜSS MicroTec SE Total equity attributable |
|||
|---|---|---|---|---|---|---|---|---|---|
| Items that will not be reclassified to profit or loss |
to profit or loss in later periods Items that will be reclassified |
||||||||
| Remeasurements on defined benefit pension plans |
Deferred taxes | Foreign currency adjustment |
Deferred taxes | ||||||
| As of January 01, 2019 | 19,116 | 71,547 | 202 | 51,118 | 3,290 - |
751 | 991 | - | 140,435 |
| Net income / loss | - | - | - | -8,743 | - | - | - | - | -8,743 |
| Total income and expenses recognized in equity | - | - | - | - | - | - | 1,816 | - | 1,816 |
| Total comprehensive income / loss | - | - | - | -8,743 | - | - | 1,816 | - | -6,927 |
| As of September 30, 2019 | 19,116 | 71,547 | 202 | 42,375 | -3,290 | 751 | 2,807 | - | 133,508 |
| As of January 01, 2020 | 19,116 | 55,822 | 202 | 50,582 | 3,610 - |
941 | 2,335 | - | 125,388 |
| Net income / loss | - | - | - | 4,908 | - | - | - | - | 4,908 |
| Total income and expenses recognized in equity | - | - | - | - | - | - | -561 | - | -561 |
| Total comprehensive income / loss | - | - | - | 4,908 | - | - | -561 | - | 4,347 |
| As of September 30, 2020 | 19,116 | 55,822 | 202 | 55,490 | -3,610 | 941 | 1,774 | - | 129,735 |
CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY (IFRS)
| Segment reporting is part of the Notes to the consolidated financial statements | |
|---|---|
| S) | |
| R | |
| F | |
| G (I | |
| N | |
| TI | |
| R | |
| O | |
| P | |
| E | |
| R | |
| T | |
| N | |
| E | |
| M | |
| G | |
| E | |
| S |
| in € thousand | Lithography | Substrate Bonder | Photomask Equipment | MicroOptics | Other | Consolidation effects | Total | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9M / 2020 | 9M / 2019 | 9M / 2020 | 9M / 2019 | 9M / 2020 | 9M / 2019 | 9M / 2020 | 9M / 2019 | 9M / 2020 | 9M / 2019 | 9M / 2020 | 9M / 2019 | 9M / 2020 | 9M / 2019 | |
| External Sales | 97,812 | 72,380 | 18,884 | 17,158 | 40,002 | 24,608 | 16,840 | 16,154 | 384 | 826 | - | - | 173,922 | 131,126 |
| Internal Sales | - | - | - | - | - | - | - | - | 8,071 | 6,890 | -8,071 | -6,890 | - | - |
| Total Sales | 97,812 | 72,380 | 18,884 | 17,158 | 40,002 | 24,608 | 16,840 | 16,154 | 8,455 | 7,716 | -8,071 | -6,890 | 173,922 | 131,126 |
| Result per segment (EBIT) | 6,155 | -8,073 | -578 | -746 | 10,969 | 4,356 | 258 | 2,670 | -4,653 | -3,882 | - | 12,151 | -5,675 | |
| Income before taxes | 6,123 | -8,106 | -587 | -768 | 10,960 | 4,355 | 259 | 2,666 | -4,956 | -3,989 | - | - | 11,799 | -5,842 |
| Significant non-cash items | 3,011 | -2,896 | -559 | 1,046 | 382 | -239 | -410 | -130 | - | - | - | - | 2,424 | -2,219 |
| Segment assets | 94,583 | 93,278 | 24,341 | 24,530 | 25,456 | 26,053 | 24,139 | 17,348 | 17,666 | 18,314 | - | - | 186,185 | 179,523 |
| thereof goodwill | 18,378 | 15,766 | - | - | - | - | - | - | - | - | - | - | 18,378 | 15,766 |
| Unallocated assets | 35,973 | 20,335 | ||||||||||||
| Total assets | 222,158 | 199,858 | ||||||||||||
| Segment liabilities | -35,001 | -21,481 | -5,361 | -3,352 | -6,964 | -6,506 | -1,624 | -2,735 | -1,055 | -2,055 | - | - | -50,005 | -36,129 |
| Unallocated liabilities | -42,418 | -30,221 | ||||||||||||
| Total liabilities | -92,423 | -66,350 | ||||||||||||
| Depreciation and amortization | 2,546 | 1,716 | 205 | 256 | 143 | 138 | 1,688 | 1,051 | 898 | 1,257 | - | - | 5,480 | 4,418 |
| thereof scheduled | 2,546 | 1,716 | 205 | 256 | 143 | 138 | 1,688 | 1,051 | 898 | 1,257 | - | - | 5,480 | 4,418 |
| thereof impairment loss | - | - | - | - | - | - | - | - | - | - | - | - | ||
| Capital expenditure | 4,280 | 1,729 | 174 | 277 | 246 | 84 | 3,019 | 1,453 | 828 | 1,427 | - | - | 8,547 | 4,970 |
| Workforce at June 30 | 616 | 561 | 98 | 103 | 150 | 146 | 100 | 91 | 33 | 34 | - | - | 997 | 935 |
| in € thousand | Sales | Capital expenditure | Assets (without Goodwill) |
|||
|---|---|---|---|---|---|---|
| 9M / 2020 | 9M / 2019 | 9M / 2020 | 9M / 2019 | 9M / 2020 | 9M / 2019 | |
| EMEA | 28,167 | 38,099 | 7,712 | 4,473 | 155,550 | 134,053 |
| North-America | 18,344 | 11,977 | - | 432 | 3,651 | 20,562 |
| Asia and Pacific | 127,411 | 81,050 | 835 | 65 | 8,660 | 9,590 |
| Consolidation effects | - | - | - | - | -54 | -448 |
| Total | 173,922 | 131,126 | 8,547 | 4,970 | 167,807 | 163,757 |
| Publication annual financial report 2020 | Apr 9, 2021 |
|---|---|
| Publication quarterly financial report Q1/2021 | May 12, 2021 |
| Annual General Meeting | Jun 16, 2021 |
| Publication half-yearly financial report 2021 | Aug 5, 2021 |
| Publication quarterly financial report Q3/2021 | Nov 11, 2021 |
Schleißheimer Straße 90 85748 Garching, Germany Phone: +49 89 32007-100 E-mail: [email protected]
Investor Relations Phone: +49 89 32007-161 Email: [email protected] www.suss.com
Forward-looking statements: Interim reports include forward-looking statements. Forward-looking statements are statements that do not present historical facts, including statements about expectations and the views of the management of SUSS MicroTec SE. These statements are based on current plans, estimates, and forecasts of the Company's management. Investors should not unreservedly rely on these statements. Forward-looking statements are to be understood in the context of the time at which they were made. The Company does not assume any obligation to update the forward-looking statements included in this report given new information or future events. This does not affect the Company's obligation to comply with its statutory responsibilities regarding information and reporting. Forward-looking statements also include risks and uncertainties. A large number of factors that are described in this report could cause actual events to deviate substantially from the forward-looking statements included in this report.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.